Artificial intelligence developer Whiterabbit.ai announced it’s teaming up with the American College of Radiology’s Data Science Institute (ACR) to facilitate the assessment of breast density and ultimately improve screening for, and treatment of, breast cancer.
The collaboration will ensure Whiterabbit’s WRDDensity, an AI-powered breast density measurement tool, is available on the ACR’s AI-Lab platform, a statement on the collaboration said. AI-Lab was developed by ACR to make it easier for radiologists to leverage AI tools as part of their workflows.
“ACR’s AI-LAB will use WRDensity in its objective to simplify the evaluation and adoption of AI for uses such as breast density assessment. In turn, this could empower radiologists to develop algorithms at their own institutions to meet their unique clinical needs," said Laura Coombs, vice president of data science and informatics at ACR, said in the statement. "ACR DSI facilitates the development, validation and implementation of artificial intelligence applications to expand radiologists’ diagnostic and clinical capabilities to improve medical care.”
Whiterabbit added that the goal of adding WRDensity to the AI-Lab platform is to improve care delivery, emphasizing that the assessment of breast density is a crucial part of identifying breast cancer and developing effective treatments.
WRDensity is the FDA-cleared, commercial AI application for measuring breast density to be added to the AI-Lab platform.
Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.